Related expression of TRKA and P75 receptors and the changing copy number of MYC-oncogenes determine the sensitivity of brain tumor cells to the treatment of the nerve growth factor in combination with cisplatin and temozolomide.

Chernov, Alexandr N; Alaverdian, Diana A; Glotov, Oleg S; Talabaev, Michael V; Urazov, Stanislav P; Shcherbak, Sergei G; Renieri, Alessandra; Frullanti, Elisa; Shamova, Olga

Chernov, Alexandr N; Alaverdian, Diana A; Glotov, Oleg S; Talabaev, Michael V; Urazov, Stanislav P; Shcherbak, Sergei G; Renieri, Alessandra; Frullanti, Elisa; Shamova, Olga.

Affiliation

Chernov AN; Department of Clinics and Genetics Investigations, Saint Petersburg City Hospital No40 of Resort District, Saint Petersburg, Russian Federation.
Alaverdian DA; Laboratory of Design and Synthesis of Biologically Active Peptides, Department of General Pathology and Pathophysiology, Institute of Experimental Medicine, Saint-Petersburg, Russian Federation.
Glotov OS; Medical Genetics, Department of Medical Biotechnologies, University of Siena, Siena, Italy.
Talabaev MV; Department of Clinics and Genetics Investigations, Saint Petersburg City Hospital No40 of Resort District, Saint Petersburg, Russian Federation.
Urazov SP; Department of Pediatric Neurosurgery, Republican Center for Neurology and Neurosurgery, Minsk, The Republic of Belarus.
Shcherbak SG; Department of Clinics and Genetics Investigations, Saint Petersburg City Hospital No40 of Resort District, Saint Petersburg, Russian Federation.
Renieri A; Department of Clinics and Genetics Investigations, Saint Petersburg City Hospital No40 of Resort District, Saint Petersburg, Russian Federation.
Frullanti E; Medical Genetics, Department of Medical Biotechnologies, University of Siena, Siena, Italy.
Shamova O; Genetica Medica, Azienda Ospedaliera Universitaria Senese, Siena, Italy.